Does Novo Nordisk (NVO) Pay a Dividend? (2026)

Yes. Novo Nordisk pays a dividend yielding roughly 3.83% as of August 2026, paid twice a year. The most recent payment on record was $1.27 per share with an ex-dividend date of March 30, 2026. That works out to a forward annual rate of about $1.80 per share. Yields move with the share price, so verify the current figure with your broker or NVO's investor relations page before relying on it.

About 3.83% as of August 2026. On a $10,000 position that is roughly $383 of dividend income a year before tax. For context, the S&P 500 yields around 1.2%, so NVO yields meaningfully more than the broad market. A higher yield is not automatically better: it can reflect a falling share price as easily as a generous payout, so it is worth checking why the number is what it is.

Novo Nordisk pays twice a year. The most recent payment on record had an ex-dividend date of March 30, 2026. To receive a given payment you have to own the shares before the ex-dividend date, not on the pay date. Confirm upcoming dates on NVO's investor relations page, because boards can change both the amount and the timing.

The ex-dividend date recorded in our August 2026 data pull is March 30, 2026. The ex-dividend date is the cutoff: buy on or after it and the seller keeps that payment, not you. Buying just before the ex-date to capture the dividend does not create free money, because the share price typically drops by roughly the dividend amount when the stock goes ex. Check NVO's investor relations page for the next confirmed date.

$1.27 per share in the most recent payment (ex-date March 30, 2026), which annualizes to about $1.80 per share. The equivalent payment a year earlier was $1.10. That is a change of 16.0% year over year.

Yes. The latest payment of $1.27 per share is above the $1.10 paid in the same slot a year earlier, an increase of about 16.0%. One raise is not a policy, though: check the multi-year record on NVO's investor relations page, since a long streak of increases is what dividend-growth investors actually look for.

Novo Nordisk paid out about 43% of its earnings as dividends, so the payout is comfortably covered. That is the range most established dividend payers sit in: enough profit is retained to keep funding the business, with room to raise the dividend if earnings grow. Nobody can guarantee a dividend: boards cut them, and a high yield is sometimes the market pricing in exactly that. Walnut is not an investment adviser and this is not a recommendation.

At a yield of about 3.83%, roughly $383 a year before tax, spread across 2 payments. That is a snapshot, not a promise: the amount changes when the company changes its payout, and your yield on cost is fixed at the price you paid, not at today's price.

Dividends from US common stock are usually qualified, meaning they are taxed at the lower long-term capital-gains rates, provided you held the shares for more than 60 days in the 121-day window around the ex-dividend date. Distributions from REITs, BDCs, and some pass-through structures are generally taxed as ordinary income instead. In an IRA or Roth the question does not arise. See our guide to how dividends are taxed. This is not tax advice.

Most brokers offer automatic reinvestment (a DRIP) that puts each NVO payment straight back into more shares, often fractional ones. Reinvesting compounds the position and is the standard choice when you do not need the cash yet. Taking the cash makes sense when you are spending the income or want to direct it elsewhere. Either way the dividend is taxable in a taxable account in the year it is paid, even if you never see the money.

Yes. Novo Nordisk pays a dividend, declared in Danish kroner and converted for ADR holders, with a modest yield as of early 2026. Danish dividends paid to US ADR holders may be subject to foreign withholding tax. Verify the current rate and tax treatment.